Genetic analyses of beta-lactamase negative ampicillin-resistant strains of Haemophilus influenzae isolated in Okinawa, Japan

Japanese Journal of Infectious Diseases

Volumn 59, Issue 1, 2006, Pages 36-41

  Kubota, Toru ^a   Higa, Futoshi ^a   Kusano, Nobuchika ^b   Nakasone, Isamu ^a   Haranaga, Shusaku ^a   Tateyama, Masao ^a   Yamane, Nobuhisa ^a   Fujita, Jiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFAZOLIN; CEFOTAXIME; CEFOTIAM; CEFPIROME; CEFTIZOXIME; CEPHEM DERIVATIVE; FTSZ PROTEIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PENICILLIN BINDING PROTEIN; PIPERACILLIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BINDING AFFINITY; BINDING SITE; DNA FINGERPRINTING; DNA POLYMORPHISM; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HAEMOPHILUS INFLUENZAE; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PENICILLIN RESISTANCE; PHENOTYPE; RESIDUE ANALYSIS; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 33644536749     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vega, R., Sadoff, H. L. and Patterson, M. J. (1976): Mechanism of ampicillin resistance in Haemophilus influenzae type B. Antimicrob. Agents Chemother., 9, 164-168.
2. Medeiros, A. A., Levesque, R. and Jacoby, G. A. (1986): An animal source for the ROB-1 β-lactamase of Haemophilus influenzae type B. Antimicrob. Agents Chemother., 29, 212-215.
3. Mendelman, P. M., Chaffin, D. O., Stull, T. L., Rubens, C. E., Mack, K. D. and Smith, A. L. (1984): Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother., 26, 235-244.
4. Mendelman, P. M., Chaffin, D. O., Musser, J., DeGroot, R., Serfass, D. A. and Selander, R. K. (1987): Genetic and phenotypic diversity among ampicillin-resistant, non-β-lactamase-producing, non-typeable Haemophilus influenzae isolates. Infect. Immun., 55, 2585-2589.
5. Mendelman, P. M., Chaffin, D. O. and Kalaitzoglou, G. (1990): Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae. J. Antimicrob. Chemother., 25, 525-534.
6. Ubukata, K., Shibasaki, Y., Yamamoto, K., Chiba, N., Hasegawa, K., Takeuchi, Y., Sunakawa, K., Inoue, M. and Konno, M. (2001): Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother., 45, 1693-1699.
7. Dabernat, H., Delmas, C., Seguy, M., Pelissier, R., Faucon, G., Bennamani, S. and Pasquier, C. (2002): Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother., 46, 2208-2218.
8. Hasegawa, K., Chiba, N., Kobayashi, R., Murayama, S. Y., Iwata, S., Sunakawa, K. and Ubukata, K. (2004): Rapidly increasing prevalence of β-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob. Agents Chemother., 48, 1509-1514.
9. Seki, H., Kasahara, Y., Ohta, K., Saikawa, Y., Sumita, R., Yachie, A., Fujita, S. and Koizumi, S. (1999): Increasing prevalence of ampicillin-resistant, non-β-lactamase-producing strains of Haemophilus influenzae in children in Japan. Chemotherapy, 45, 15-21.
10. Nakasone, I., Onaga, S., Furukawa, H., Saitoh, H., Yamane, N. and Sato, Y. (2002): Antimicrobial susceptibility and prevalence of β-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000. Jpn. J. Antibiot., 55, Suppl. A, 95-110 (in Japanese).
11. National Committee for Clinical Laboratory Standards (2003): Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6, National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Dargis, M. and Malouin, F. (1994): Use of biotinylated β-lactams and chemiluminescence for study and purification of penicillin-binding proteins in bacteria. Antimicrob. Agents Chemother., 38, 973-980.
13. Sharma, A., Kaur, R., Ganguly, N. K., Singh, P. D. and Chakraborti, A. (2002): Subtype distribution of Haemophilus influenzae isolates from North India. J. Med. Microbiol., 51, 399-404.
14. Parr, T. R., Jr. and Bryan, L. E. (1984): Mechanism of resistance of an ampicillin-resistant, β-lactamase-negative clinical isolate of Haemophilus influenzae type b to β-lactam antibiotics. Antimicrob. Agents Chemother., 25, 747-753.
15. Kaczmarek, F. S., Gootz, T. D., Dib-Haji, F., Shang, W., Hallowell, S. and Cronan, M. (2004): Genetic and molecular characterization of β-lactamase-negative-ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob. Agents Chemother., 48, 1630-1639.
16. Morikawa, Y., Kitazato, M., Mitsuyama, J., Mizunaga, S., Minami, S. and Watanabe, Y. (2004): In vitro activities of piperacillin against β -lactamase-negative-ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother., 48, 1229-1234.
17. Matic, V., Bozdogan, B., Jacobs, M. R., Ubukata, K. and Appelbaum, P. C. (2003): Contribution of β-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in β-lactamase-positive, amoxicillin/ clavulanate-resistant Haemophilus influenzae. J. Antimicrob. Chemother., 52, 1018-1021.
18. Osaki, Y., Sanbongi, Y., Ishikawa, M., Kataoka, H., Suzuki, T., Maeda, K. and Ida, T. (2005): Genetic approach to study relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae β - lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob. Agents Chemother., 49, 2834-2839.
19. Watanabe, H., Hoshino, K., Sugita, R., Asoh, N., Watanabe, K., Oishi, K. and Nagatake, T. (2004): Possible high rate of transmission of nontypeable Haemophilus influenzae, including β-lactamase-negative-ampicillin-resistant strains, between children and their parents. J. Clin. Microbiol., 42, 362-365.
20. Smith-Vaughan, H., Sriprakash, K. S., Leach, A. J., Mathews, J. D. and Kemp, D. J. (1998): Low genetic diversity of Haemophilus influenzae type b compared to nonencapsulated H. influenzae in a population in which H. influenzae is highly endemic. Infect. Immun., 66, 3404-3409.
21. Musser, J. M., Kroll, J. S., Moxon, R. and Selander, R. (1988): Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc. Natl. Acad. Sci. USA, 85, 7758-7762.